CDKN2A and neoplasm: Recent studies with mice demonstrated that removal of p16INK4a-positive cells prevented or slowed the deterioration of several tissues and organs, delayed tumor growth [15], and reduced metastasis in mice exposed to cytotoxic cancer treatments [16].